Back

Risk adjusted comparison of in-hospital outcomes of transapical transcatheter and surgical aortic valve replacement

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Transcatheter aortic interventions Aortic Valve Stenosis ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Peter Stachon

Praxis Sandstrsse, Freiburg (Germany)

8 More presentations in this session

Presentation thumbnail
Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation
Doctor J. Butt (Copenhagen, DK)
Abstract
Presentation thumbnail
Long-term mortality in patients with paradoxical low-flow low-gradient versus normal-flow high-gradient aortic stenosis undergoing transcatheter aortic valve implantation
Doctor L. Fusini (Milan, IT)
Abstract
Presentation thumbnail
Pseudo-discordance mimicking low-flow low-gradient AS in TAVR patients with severe symptomatic aortic stenosis
Doctor R. Kuperstein (Ramat Gan, IL)
Abstract
Presentation thumbnail
Predictors of renal function improvement in patients with chronic kidney disease undergoing TAVR
Mr M. Lemes (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Inflammatory leukocyte phenotypes are associated with increased mortality after transfemoral transcatheter aortic valve implantation
Doctor J. Hoffmann (Frankfurt, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Transcatheter aortic interventions

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources